Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Early balding linked to higher heart disease risk.

Hair loss in women may have causes other than hormones.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Some skin diseases and their treatments can negatively affect male fertility.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Hair loss in young men in Central India is linked to severe heart disease.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

ROS may affect hair loss related to hormones.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Early balding at 40 increases prostate cancer risk.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

New steroids were effective in blocking male hormone receptors in hamster prostates.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.